CD27 and neoplasm: Tumor growth was clearly reduced and survival of the mice was prolonged compared to untreated controls (Fig. 5) suggesting a synergistic effect of CD27 deficiency in the Treg compartment and blockade of the PD-1 signaling pathway on antitumor immunity.